# A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

> **NCT05470387** · PHASE3 · TERMINATED · sponsor: **Palisade Bio** · enrollment: 23 (actual)

## Conditions studied

- Ileus
- Gastro-Intestinal Disorder

## Interventions

- **DRUG:** LB1148
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05470387
- **Lead sponsor:** Palisade Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-28
- **Primary completion:** 2023-03-06
- **Final completion:** 2023-08-11
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470387, "A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05470387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*